ArticleCancer chemotherapy and pharmacology2024

Pharmacokinetic study of capivasertib and the CYP3A4 substrate midazolam in patients with advanced solid tumors.

Claire Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.